Benign Prostatic Hyperplasia Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug (Alpha Blockers, 5-Aplha Reductase Inhibitors, Others), By Surgical Treatment (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Laser Therapy, Prostatic Stenting, Others), Countries and Companies Report
Benign Prostatic Hyperplasia Treatment is projected to register a 8.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets